Key Points• The atypical chemokine receptor regulates T celldevelopment in the thymus and inhibits spontaneous autoimmunity.The atypical chemokine receptor CCX-CKR regulates bioavailability of CCL19, CCL21, and CCL25, homeostatic chemokines that play crucial roles in thymic lymphopoiesis. Deletion of CCX-CKR results in accelerated experimental autoimmunity induced by immunization. Here we show that CCX-CKR deletion also increases incidence of a spontaneous Sjö gren's syndrome-like pathology, characterized by lymphocytic infiltrates in salivary glands and liver of CCX-CKR ؊/؊ mice, suggestive of a defect in self-tolerance when CCX-CKR is deleted. This prompted detailed examination of the thymus in CCX-CKR ؊/؊ mice. Negatively selected mature SP cells were less abundant in CCX-CKR ؊/؊ thymi, yet expansion of both DP and immature SP cells was apparent. Deletion of CCX-CKR also profoundly reduced proportions of DN3 thymocyte precursors and caused DN2 cells to accumulate within the medulla. These effects are likely driven by alterations in thymic stroma as CCX-CKR ؊/؊ mice have fewer cTECs per thymocyte, and cTECs express the highest level of CCX-CKR in the thymus. A profound decrease in CCL25 within the thymic cortex was observed in CCX-CKR ؊/؊ thymi, likely accounting for their defects in thymocyte distribution and frequency. These findings identify a novel role for CCX-CKR in regulating cTEC biology, which promotes optimal thymocyte development and selection important for self-tolerant adaptive immunity. (Blood. 2013;121(1):118-128)
IntroductionChemokines direct leukocyte traffic during development, homeostasis, and during immune responses. 1 However, chemokine regulation at the posttranslational level is poorly understood. A subfamily of atypical chemokine receptors has been identified that control chemokine levels and localization via high-affinity chemokine binding that is uncoupled from classic ligand-driven signal transduction cascades, resulting instead in chemokine sequestration, degradation, or transcytosis. 2,3 The in vivo significance of these receptors has mainly been described for D6 and DARC, which regulate the biology of inflammatory chemokines after immune and inflammatory responses. 3 Another of these atypical chemokine receptors, known as CCX-CKR (alternatively CCR11 or CCRL1), binds with high affinity to the homeostatic CCR7 ligands CCL19, CCL21, and the CCR9 ligand CCL25, 4-6 chemokines that play a significant role during lymphocyte development and homeostasis. 1,7 CCX-CKR has previously been shown to sequester and degrade CCR7-ligand chemokines in vitro and in vivo, thereby influencing adaptive immune responses. 4,8 Furthermore, CCX-CKR deletion leads to early onset and increased disease in experimental autoimmune encephalomyelitis, 8 a mouse model of multiple sclerosis, dependent on activation of T cells specific for self-antigen. This raises the possibility that T-cell selection and development are regulated by CCX-CKR.Deletion of autoreactive T cells occurs in the thymus where BM-derived pre...